US clears Pfizer’s biosimilar or Epogen, Procrit by Selina McKee | May 16, 2018 | News | 0 The US Food and Drug Administration has approved Pfizer’s Retacrit, a biosimilar of Amgen’s Epogen and Johnson & Johnson’s Procrit. Read More
Pfizer’s Epogen/Procrit biosimilar wins US backing by Selina McKee | May 26, 2017 | News | 0 Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications. Read More